Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W C Janzen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Versicherungsmedizin|July 4, 2002
[Comment on J. Fritze: Stroke management in Germany]R W C Janzen
Zeitschrift Fur Rheumatologie|February 29, 2012
[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession]R W C Janzen, W D Ludwig,
Der Nervenarzt|February 1, 2021
[Irreversible brain death-Part 2. Spinalization phenomena]R W C Janzen, J Lambeck, W Niesen, et al.
Der Nervenarzt|July 25, 2020
[Irreversible loss of brain function-Part 1: pitfalls in clinical diagnosis]R W C Janzen, J Lambeck, W-D Niesen, et al.
Clinical Neuropathology|June 18, 2003
Mini-infarct encephalopathy associated with uncommon microvessel convolute formation presenting with presenile dementiaJ A P van de Nes, R Zimmer, R W C Janzen, et al.
Archives of Internal Medicine|September 15, 2004
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study GroupPeter U Heuschmann, Peter L Kolominsky-Rabas, Bjoern Misselwitz, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Versicherungsmedizin|July 4, 2002
[Comment on J. Fritze: Stroke management in Germany]R W C Janzen
Zeitschrift Fur Rheumatologie|February 29, 2012
[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession]R W C Janzen, W D Ludwig,
Der Nervenarzt|February 1, 2021
[Irreversible brain death-Part 2. Spinalization phenomena]R W C Janzen, J Lambeck, W Niesen, et al.
Der Nervenarzt|July 25, 2020
[Irreversible loss of brain function-Part 1: pitfalls in clinical diagnosis]R W C Janzen, J Lambeck, W-D Niesen, et al.
Clinical Neuropathology|June 18, 2003
Mini-infarct encephalopathy associated with uncommon microvessel convolute formation presenting with presenile dementiaJ A P van de Nes, R Zimmer, R W C Janzen, et al.
Archives of Internal Medicine|September 15, 2004
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study GroupPeter U Heuschmann, Peter L Kolominsky-Rabas, Bjoern Misselwitz, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 1